Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Muscle-derived interleukin 6 increases exercise capacity by signaling in osteoblasts
Subrata Chowdhury, … , Jens Brüning, Gerard Karsenty
Subrata Chowdhury, … , Jens Brüning, Gerard Karsenty
Published February 20, 2020
Citation Information: J Clin Invest. 2020;130(6):2888-2902. https://doi.org/10.1172/JCI133572.
View: Text | PDF
Research Article Bone biology

Muscle-derived interleukin 6 increases exercise capacity by signaling in osteoblasts

  • Text
  • PDF
Abstract

Given the numerous health benefits of exercise, understanding how exercise capacity is regulated is a question of paramount importance. Circulating interleukin 6 (IL-6) levels surge during exercise and IL-6 favors exercise capacity. However, neither the cellular origin of circulating IL-6 during exercise nor the means by which this cytokine enhances exercise capacity has been formally established yet. Here we show through genetic means that the majority of circulating IL-6 detectable during exercise originates from muscle and that to increase exercise capacity, IL-6 must signal in osteoblasts to favor osteoclast differentiation and the release of bioactive osteocalcin in the general circulation. This explains why mice lacking the IL-6 receptor only in osteoblasts exhibit a deficit in exercise capacity of similar severity to the one seen in mice lacking muscle-derived IL-6 (mIL-6), and why this deficit is correctable by osteocalcin but not by IL-6. Furthermore, in agreement with the notion that IL-6 acts through osteocalcin, we demonstrate that mIL-6 promotes nutrient uptake and catabolism into myofibers during exercise in an osteocalcin-dependent manner. Finally, we show that the crosstalk between osteocalcin and IL-6 is conserved between rodents and humans. This study provides evidence that a muscle-bone-muscle endocrine axis is necessary to increase muscle function during exercise in rodents and humans.

Authors

Subrata Chowdhury, Logan Schulz, Biagio Palmisano, Parminder Singh, Julian M. Berger, Vijay K. Yadav, Paula Mera, Helga Ellingsgaard, Juan Hidalgo, Jens Brüning, Gerard Karsenty

×

Figure 5

IL-6 favors osteoclastogenesis by signaling in osteoblasts.

Options: View larger image (or click on image) Download as PowerPoint
IL-6 favors osteoclastogenesis by signaling in osteoblasts.
(A and B) Co...
(A and B) Coculture of Il6rfl/fl osteoblasts with Il6rfl/fl osteoclast precursor cells (OPCs), Il6rosb–/– osteoblasts with Il6fl/fl OPCs, and Il6rfl/fl osteoblasts with Il6rosb–/– OPCs in the presence of IL-6 and sIL-6r. (A) Quantification of the number of osteoclasts (OCs), TRAP activity, and the number of nuclei per TRAP+ osteoclast. (B) Expression of resorbing-activity markers Acp5, cathepsin K (Ctsk), Atp6v0d2, Dc-stamp, and Clcn7 in mouse osteoclasts (WT OCs). (C) Coculture in the presence of IL-6 and sIL-6r of (i) Il6rfl/fl osteoblasts with Il6rfl/fl OPCs, (ii) Il6rosb–/– osteoblasts with Il6fl/fl OPCs, or (iii) Il6r–/– osteoblasts with Il6rosb–/– OPCs. TRAP activity and quantification of the number of osteoclasts. (D and E) IL6r–/– osteoblasts were generated by infecting Il6rfl/fl osteoblasts with adenovirus expressing Cre recombinase and coculturing with Il6rfl/fl osteoblasts in the absence or presence of IL-6 in the culture medium. Similarly, IL6r–/– OPCs were generated by infecting Il6rfl/fl OPCs with adenovirus expressing Cre recombinase and coculturing with Il6rfl/fl osteoblasts in the absence or presence of IL-6. (D) Quantification of TRAP activity, of the number of nuclei per TRAP+ osteoclast, and gene expression of resorption markers (Acp5, Dc-stamp, and Clcn7). (E) Cocultures in the presence of IL-6 in the culture medium, quantification of TRAP activity, the number of nuclei per TRAP+ osteoclast, and expression of resorption markers (Acp5, Atp6v0d2, Dc-stamp, and Clcn7). These results are representative of 3 independent experiments with triplicate samples. Data in A–E were analyzed by 2-way ANOVA followed by Tukey’s post hoc test; the relative TRAP activity data in A and C–E were analyzed by 2-tailed unpaired t test. Error bars represent SEM. *P < 0.05; **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts